PPC
BIIB icon

Park Place Capital’s Biogen BIIB Stock Holding History

Park Place Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.64K Buy
40
+7
+21% +$1.34K ﹤0.01% 869
2026
Q1 		$6.05K Buy
33
+22
+200% +$4.05K ﹤0.01% 659
2025
Q4 		$1.94K Hold
11
– – ﹤0.01% 723
2025
Q3 		$1.54K Hold
11
– – ﹤0.01% 730
2025
Q2 		$1.43K Hold
11
– – ﹤0.01% 754
2025
Q1 		$1.5K Buy
+11
New +$1.57K ﹤0.01% 756
2024
Q4 		– Sell
-7
Closed -$1.36K – 817
2024
Q3 		$1.36K Hold
7
– – ﹤0.01% 811
2024
Q2 		$1.62K Hold
7
– – ﹤0.01% 794
2024
Q1 		$1.51K Buy
+7
New +$1.64K ﹤0.01% 860
2023
Q4 		– Sell
-7
Closed -$1.8K – 880
2023
Q3 		$1.8K Sell
7
-2
-22% -$535 ﹤0.01% 935
2023
Q2 		$2.56K Sell
9
-12
-57% -$3.57K ﹤0.01% 926
2023
Q1 		$5.84K Buy
21
+14
+200% +$3.87K ﹤0.01% 847
2022
Q4 		$2K Buy
+7
New +$1.98K ﹤0.01% 937

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Park Place Capital's BIIB Position: Q2 2026 in Review

Park Place Capital increased its Biogen (BIIB) stake by 21% in Q2 2026, buying an estimated $1.34K and bringing the position to 40 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #869.

Park Place Capital first reported a position in BIIB in Q4 2022 and has held it in 13 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Park Place Capital held 40 shares of Biogen worth $8.64K as of Q2 2026.
  • Park Place Capital bought 7 Biogen shares in Q2 2026, an estimated $1.34K.
  • Biogen made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #869 holding.
  • Park Place Capital first reported a position in Biogen in Q4 2022 and has held it in 13 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.